GlassScriptPhysician profile
Melissa J Cohen
NPI 1174763262
$4,942.42
in general payments reported to CMS, 2019-2025
34 companies · $2,375 in 2025
The $2,375 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.52 · 2020: $116 · 2021: $317 · 2022: $366 · 2023: $586 · 2024: $1,099 · 2025: $2,375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,161 · Long Term Medical Supply Or Device Loan: $1,446 · Education: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,161.11 |
| Long Term Medical Supply Or Device Loan | $1,446.39 |
| Education | $451.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,213.40 | 2021-2025 | |
| Daiichi Sankyo INC. | $404.23 | 2023-2025 | Datroway, Enhertu |
| Pfizer INC. | $205.71 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $179.19 | 2024-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Astellas Pharma US INC | $178.34 | 2023 | Padcev |
| Incyte Corporation | $166.77 | 2024-2025 | Monjuvi, Zynyz, Jakafi |
| Bayer Healthcare Pharmaceuticals INC. | $140.49 | 2025 | |
| Aveo Pharmaceuticals, INC. | $133.77 | 2025 | |
| Covidien LP | $103.66 | 2020 | |
| Glaxosmithkline, LLC. | $101.14 | 2025 | Jemperli |
| Tempus Ai, INC | $95.98 | 2025 | Xt Cdx |
| Astrazeneca Pharmaceuticals LP | $89.28 | 2024-2025 | Enhertu, Imfinzi |
| E.R. Squibb & Sons, L.L.C. | $75.08 | 2024-2025 | Opdivo |
| Seagen INC. | $72.73 | 2025 | |
| Puma Biotechnology, INC. | $71.05 | 2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $69.74 | 2025 | Itovebi |
| Abbvie INC. | $59.80 | 2024-2025 | |
| Lilly USA, LLC | $54.07 | 2025 | Verzenio, Jaypirca |
| Takeda Pharmaceuticals U.S.A., INC. | $53.27 | 2025 | Iclusig |
| Array Biopharma INC | $51.07 | 2025 | Lorbrena, Padcev, Braftovi |
| Janssen Biotech, INC. | $49.62 | 2025 | Talvey, Darzalex, Tecvayli |
| Genmab U.S., INC. | $47.24 | 2023-2024 | Tivdak |
| Tesaro, INC. | $46.29 | 2019 | |
| Foundation Medicine, INC. | $45.93 | 2019-2023 | |
| Kite Pharma, INC. | $29.73 | 2025 | |
| Eisai INC. | $29.20 | 2025 | |
| Beone Medicines USA, INC. | $26.19 | 2025 | Brukinsa |
| Stemline Therapeutics INC. | $25.65 | 2025 | Orserdu |
| Gilead Sciences, INC. | $23.91 | 2023 | |
| Emd Serono, INC. | $23.03 | 2025 | |
| Celgene Corporation | $20.63 | 2025 | Reblozyl |
| Agios Pharmaceuticals, INC. | $20.50 | 2025 | Pyrukynd |
| Adaptive Biotechnologies Corporation | $19.74 | 2025 | Clonoseq |
| Janssen Pharmaceuticals, INC | $15.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.